1 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians 2018;68:394-424.
2 Zhang X, Yang Q: Association between serum copper levels and lung cancer risk: A meta-analysis. The Journal of international medical research 2018:300060518798507.
3 Ou SH: Lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy? Journal of clinical pathology 2013;66:839-846.
4 Islami F, Torre LA, Jemal A: Global trends of lung cancer mortality and smoking prevalence. Translational lung cancer research 2015;4:327-338.
5 Liu C, Cui H, Gu D, Zhang M, Fang Y, Chen S, Tang M, Zhang B, Chen H: Genetic polymorphisms and lung cancer risk: Evidence from meta-analyses and genome-wide association studies. Lung cancer (Amsterdam, Netherlands) 2017;113:18-29.
6 Papadopoulos D, Papadoudis A, Kiagia M, Syrigos K: Nonpharmacologic Interventions for Improving Sleep Disturbances in Patients With Lung Cancer: A Systematic Review and Meta-analysis. Journal of pain and symptom management 2018;55:1364-1381.e1365.
7 Radouani F, El Yazouli L, Elyazghi Z, Hejaji H, Alami AA, Elmdaghri N: Chlamydia pneumoniae sero-prevalence in Moroccan patients with cardiovascular diseases. Infection, disease & health 2018
8 Schmidt SM, Muller CE, Bruns R, Wiersbitzky SK: Bronchial Chlamydia pneumoniae infection, markers of allergic inflammation and lung function in children. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2001;12:257-265.
9 Burillo A, Bouza E: Chlamydophila pneumoniae. Infectious disease clinics of North America 2010;24:61-71.
10 Kuo CC, Jackson LA, Campbell LA, Grayston JT: Chlamydia pneumoniae (TWAR). Clinical microbiology reviews 1995;8:451-461.
11 Laurila AL, Anttila T, Läärä E, Bloigu A, Virtamo J, Albanes D, Leinonen M, Saikku P: Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer. International journal of cancer 1997;74:31‐34.
12 Smith JS, Kumlin U, Nyberg F, Fortes C, Zaridze D, Ahrens W, Bruske-Hohlfeld I, Constantinescu V, Ting J, Benhamou S, Simonato L, Boman J, Gaborieau V, Boffetta P: Lack of association between serum antibodies of Chlamydia pneumoniae infection and the risk of lung cancer. International journal of cancer 2008;123:2469-2471.
13 Konstantopoulou S, Karachalios S, Mourikis A, Logothetis E, Strandzalis N, Demeridou S, Kontou-Castellanou C, Kouskouni E: Chronic Chlamydia pneumoniae infection and risk of lung cancer. Clin microbiol infect, Suppl 2003;9:203.
14 Aksaray S, Suzuk S, Guvener E, Unsal E, Urunal B, Aksaray F, Han S, Sakinci U: Association of Chlamydia pneumoniae seropositivity and lung cancer. Clin microbiol infect, Suppl 2004;10:661.
15 Furlan AD, Pennick V, Bombardier C, van Tulder M: 2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group. Spine 2009;34:1929-1941.
16 Chaturvedi AK, Gaydos CA, Agreda P, Holden JP, Chatterjee N, Goedert JJ, Caporaso NE, Engels EA: Chlamydia pneumoniae infection and risk for lung cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19:1498-1505.
17 Fei H, Cailin: Association of Chlamydia pneumoniae infection with risk of lung cancer. Chinese Journal of Public Health 2014;30:70-73.
18 Jackson LA, Wang SP, Nazar-Stewart V, Grayston JT, Vaughan TL: Association of Chlamydia pneumoniae immunoglobulin A seropositivity and risk of lung cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2000;9:1263-1266.
19 Kocazeybek B: Chronic Chlamydophila pneumoniae infection in lung cancer, a risk factor: A case-control study. Journal of Medical Microbiology 2003;52:721-726.
20 Koyi H, Branden E, Gnarpe J, Gnarpe H, Steen B: An association between chronic infection with Chlamydia pneumoniae and lung cancer. A prospective 2-year study. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2001;109:572-580.
21 Littman AJ, White E, Jackson LA, Thornquist MD, Gaydos CA, Goodman GE, Vaughan TL: Chlamydia pneumoniae infection and risk of lung cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13:1624-1630.
22 Liu Z, Su M, Yu SC, Yin ZH, Zhou BS: Association of Chlamydia pneumoniae immunoglobulin G antibodies with the risk of lung cancer among non-smoking women in Liaoning, China. Thoracic cancer 2010;1:126-129.
23 Meichun Z, Qoing C, Chengping H, Tiesheng H: Chlamydia pneumoniae infection in patients with lung cancer and chronic obstructive pulmonary disease. China Journal of Modern Medicine 2004;14:31-34,40.
24 Xiumei W: Investigation of chlamydia pneumoniae infection in respiratory inpatients. Chinese Community Doctors 2010;12:81.
25 Yanbin C, Yueduo T, Chunhua L, Jianan H, Jiayong M, Ling W, Rongmei Z: Association between chlamydia pneumoniae infection and lung cancer. Jiangsu Medical Journal 2005;31:306.
26 Yanbin C, Yueduo T, Chunhua L, Jianan H, Minrong Z: Serological study of an association between chronic Chlamydia pneumoniae infection and respiratory tract diseases in the elderly. Practical Geriatrics 2004;18:303-304,307.
27 Yuqing C, Liming L, Fengchao W, Peiying X, Anchao W, Fengzhen X: Study on Chlamydia pneumoniae infection in patients with Lung Cancer. Chinese journal of zoonoses 2001;17:46-49.
28 Minguet J, Smith KH, Bramlage P: Targeted therapies for treatment of non-small cell lung cancer--Recent advances and future perspectives. International journal of cancer 2016;138:2549-2561.
29 Qunxia C, Lin C: Association of Cpn infection with lung cancer: a meta-analysis of serological studies. Chinese Journal of Public Health 2015;31:1095-1099.
30 Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE: Increased cell division as a cause of human cancer. Cancer research 1990;50:7415-7421.
31 Bjorkholm B, Falk P, Engstrand L, Nyren O: Helicobacter pylori: resurrection of the cancer link. Journal of internal medicine 2003;253:102-119.
32 Sipponen P: Gastric cancer: pathogenesis, risks, and prevention. Journal of gastroenterology 2002;37 Suppl 13:39-44.
33 Chumduri C, Gurumurthy RK, Zadora PK, Mi Y, Meyer TF: Chlamydia infection promotes host DNA damage and proliferation but impairs the DNA damage response. Cell host & microbe 2013;13:746-758.
34 Gaydos CA: Growth in vascular cells and cytokine production by Chlamydia pneumoniae. The Journal of infectious diseases 2000;181 Suppl 3:S473-478.
35 Geng Y, Shane RB, Berencsi K, Gonczol E, Zaki MH, Margolis DJ, Trinchieri G, Rook AH: Chlamydia pneumoniae inhibits apoptosis in human peripheral blood mononuclear cells through induction of IL-10. Journal of immunology (Baltimore, Md : 1950) 2000;164:5522-5529.
36 Biasucci LM, Liuzzo G, Ciervo A, Petrucca A, Piro M, Angiolillo DJ, Crea F, Cassone A, Maseri A: Antibody response to chlamydial heat shock protein 60 is strongly associated with acute coronary syndromes. Circulation 2003;107:3015-3017.
37 Mayer J, Woods ML, Vavrin Z, Hibbs JB, Jr.: Gamma interferon-induced nitric oxide production reduces Chlamydia trachomatis infectivity in McCoy cells. Infection and immunity 1993;61:491-497.
38 Arroyo PL, Hatch-Pigott V, Mower HF, Cooney RV: Mutagenicity of nitric oxide and its inhibition by antioxidants. Mutation research 1992;281:193-202.
39 Bauer AK, Fostel J, Degraff LM, Rondini EA, Walker C, Grissom SF, Foley J, Kleeberger SR: Transcriptomic analysis of pathways regulated by toll-like receptor 4 in a murine model of chronic pulmonary inflammation and carcinogenesis. Molecular cancer 2009;8:107.